Jens Samol

Jens Samol

Tan Tock Seng Hospital - Singapur / Singapore
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4965327
person_outline Jens Samol's MOST POPULAR ARTICLES
1-) Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial Nature medicine 27 (9), 1536-1543, 2021
2-) Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease
3-) Safety and tolerability of the poly (ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid … Investigational new drugs 30, 1493-1500, 2012
4-) Toripalimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: the JUPITER-02 randomized clinical trial Jama 330 (20), 1961-1970, 2023
5-) Toripalimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: the JUPITER-02 randomized clinical trial Jama 330 (20), 1961-1970, 2023